Health Condition 1: N72- Inflammatory disease of cervix uteri
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Women with age between 20 to 40 years 2.Women with Intact uterus 3.Women suffering from any/ more/all of the following Symptoms- Abundant vaginal discharge , pelvic pain, Post coital bleeding, dyspareunia.
Exclusion criteria
Exclusion criteria: 1.Pap smear with premalignant and malignant changes 2.Active genital tract infections 3.Women who are virgin or pregnant or lactating or have attained menopause 4.Women with medical history of OR suffering from hypertension/ diabetes mellitus/ bleeding disorder/any other immunocompromising disease 5.Women taking Oral contraceptive pills 6.Females with history of cervical Neoplasia or premalignant cervical lesion (CIN-1 & CIN-2)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the symptomatic improvement among patients after cryotherapy Timepoint: 1)Baseline:07/11/22 to 07/11/23 2) 1 month (4 weeks) 3) 3 months(12 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) To document any complications of cryotherapy . (2) To analyze the features associated with success of cryotherapy Timepoint: 1)Baseline 07/11/22 to 07/11/23 2) 1 month (4 weeks) 3) 3 months (12 weeks) | — |
Countries
India
Contacts
Rohilkhand Medical College, Bareilly,UP